MEDAPP S.A. ZY -10 Market Cap ($5.91 Million)
Market Cap & Net Worth: MEDAPP S.A. ZY -10 (WQ1)
MEDAPP S.A. ZY -10 market cap. MEDAPP S.A. ZY -10 (F:WQ1) has a market capitalization of $5.91 Million (€5.05 Million) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #28181 globally and #2423 in its home market, demonstrating a -6.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MEDAPP S.A. ZY -10's stock price €0.02 by its total outstanding shares 250132454 (250.13 Million). Also see cash flow conversion of MEDAPP S.A. ZY -10 for how efficiently the company converts equity into cash flow.
MEDAPP S.A. ZY -10 Market Cap History (2021–2026)
MEDAPP S.A. ZY -10 market cap history from 2021 to 2026. Data shows change from $57.61 Million to $5.91 Million (-34.33% CAGR). Check MEDAPP S.A. ZY -10 stock quote for real-time trading data and today's change.
MEDAPP S.A. ZY -10 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MEDAPP S.A. ZY -10's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore MEDAPP S.A. ZY -10 (WQ1) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.19x
MEDAPP S.A. ZY -10's market cap is 1.19 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $57.61 Million | $12.71 Million | $4.12 Million | 4.53x | 13.97x |
| 2022 | $23.39 Million | $6.73 Million | $609.00K | 3.47x | 38.41x |
| 2023 | $19.65 Million | $5.74 Million | -$3.13 Million | 3.43x | N/A |
| 2024 | $8.31 Million | $7.20 Million | $2.04 Million | 1.15x | 4.08x |
| 2025 | $4.56 Million | $3.84 Million | -$2.15 Million | 1.19x | N/A |
Competitor Companies of WQ1 by Market Capitalization
Companies near MEDAPP S.A. ZY -10 in the global market cap rankings as of November 4, 2026. Also see how large is MEDAPP S.A. ZY -10's balance sheet for a full breakdown of the balance sheet.
Key companies related to MEDAPP S.A. ZY -10 by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #717 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1658 globally with a market cap of $14.29 Billion USD ( AU$20.19 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2014 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2073 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #717 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $307.00 |
| #1658 | Pro Medicus Ltd | AU:PME | $14.29 Billion | AU$193.27 |
| #2014 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $78.48 |
| #2073 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $66.26 |
Market Capitalization of MEDAPP S.A. ZY -10 (2021–2026)
Market capitalization of MEDAPP S.A. ZY -10 from 2021 to today. Between 2021 and today, MEDAPP S.A. ZY -10's market cap moved from $57.61 Million to $ 5.91 Million, with a yearly change of -34.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €5.91 Million | +29.49% |
| 2025 | €4.56 Million | -45.07% |
| 2024 | €8.31 Million | -57.74% |
| 2023 | €19.65 Million | -16.00% |
| 2022 | €23.39 Million | -59.39% |
| 2021 | €57.61 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of MEDAPP S.A. ZY -10 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.91 Million USD |
| MoneyControl | $5.91 Million USD |
| MarketWatch | $5.91 Million USD |
| marketcap.company | $5.91 Million USD |
| Reuters | $5.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About MEDAPP S.A. ZY -10
MedApp S.A. engages in the development of solutions to support imaging diagnostics and digital medicine in Poland, rest of the European Union, and internationally. The company offers CarnaLife Holo, a technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. HoloComm, an innovative solution for easy and convenient work on files in 3D… Read more